Literature DB >> 21312093

[Patient reported outcome monitoring using a tablet PC is suitable for measuring quality of life in patients with gliomas].

Bernhard Holzner1, Gabriele Schauer-Maurer, Guenter Stockhammer, Armin Muigg, Markus Hutterer, Johannes Giesinger.   

Abstract

A computer-based tool for the monitoring of patient-related outcomes, the "Computer-based Health Evaluation System" (CHES) was developed at the medical university of Innsbruck. The software-generated graphic QOL profiles were found to be an important tool for screening patients for clinically relevant problems and were successfully used in oncology, geriatrics, psychiatry, and psychosomatics. The authors report their experience with CHES in 34 patients with recurrent gliomas. The computer-based QoL monitoring was repeated in median 5.4 times per patients and found feasible and well accepted by patients and personnel.

Entities:  

Mesh：

Year:  2011        PMID： 21312093     DOI： 10.1007/s10354-011-0872-z

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  16 in total

1.  Health-related quality of life in patients with glioblastoma: a randomised controlled trial.

Authors:  Martin J B Taphoorn; Roger Stupp; Corneel Coens; David Osoba; Rolf Kortmann; Martin J van den Bent; Warren Mason; René O Mirimanoff; Brigitta G Baumert; Elizabeth Eisenhauer; Peter Forsyth; Andrew Bottomley
Journal:  Lancet Oncol       Date:  2005-12       Impact factor: 41.316

2.  The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.

Authors:  Adelheid Wöhrer; Thomas Waldhör; Harald Heinzl; Monika Hackl; Johann Feichtinger; Ulrike Gruber-Mösenbacher; Andreas Kiefer; Hans Maier; Reinhard Motz; Angelika Reiner-Concin; Bernd Richling; Carmen Idriceanu; Michael Scarpatetti; Roland Sedivy; Hans-Christian Bankl; Wolfgang Stiglbauer; Matthias Preusser; Karl Rössler; Johannes Andreas Hainfellner
Journal:  J Neurooncol       Date:  2009-06-28       Impact factor: 4.130

3.  Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial.

Authors:  Symone B Detmar; Martin J Muller; Jan H Schornagel; Lidwina D V Wever; Neil K Aaronson
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  Effect of disease burden on health-related quality of life in patients with malignant gliomas.

Authors:  D Osoba; M Brada; M D Prados; W K Yung
Journal:  Neuro Oncol       Date:  2000-10       Impact factor: 12.300

5.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Authors:  D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

6.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

Review 7.  Temozolomide for high grade glioma.

Authors:  Michael G Hart; Robert Grant; Ruth Garside; Gabriel Rogers; Margaret Somerville; Ken Stein
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

8.  Patient-reported outcomes measurement and management with innovative methodologies and technologies.

Authors:  Chih-Hung Chang
Journal:  Qual Life Res       Date:  2007-05-26       Impact factor: 4.147

9.  Feasibility and compliance of automated measurement of quality of life in oncology practice.

Authors:  E P Wright; P J Selby; M Crawford; A Gillibrand; C Johnston; T J Perren; R Rush; A Smith; G Velikova; K Watson; A Gould; A Cull
Journal:  J Clin Oncol       Date:  2003-01-15       Impact factor: 44.544

10.  Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors.

Authors:  Bernhard Holzner; Georg Kemmler; David Cella; Christina De Paoli; Verena Meraner; Martin Kopp; Richard Greil; W Wolfgang Fleischhacker; Barbara Sperner-Unterweger
Journal:  Acta Oncol       Date:  2004       Impact factor: 4.089
View more
  3 in total

Review 1.  [The benefits of using patient-reported outcomes in cancer treatment: an overview].

Authors:  Lisa M Wintner; Johannes M Giesinger; Georg Kemmler; Monika Sztankay; Anne Oberguggenberger; Eva-Maria Gamper; Barbara Sperner-Unterweger; Bernhard Holzner
Journal:  Wien Klin Wochenschr       Date:  2012-04-27       Impact factor: 1.704

Review 2.  Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.

Authors:  Markus Hutterer; Elke Hattingen; Christoph Palm; Martin Andreas Proescholdt; Peter Hau
Journal:  Neuro Oncol       Date:  2014-12-27       Impact factor: 12.300

Review 3.  Reporting of patient-reported health-related quality of life in adults with diffuse low-grade glioma: a systematic review.

Authors:  Daniel M Fountain; Dominic Allen; Alexis J Joannides; Dipankar Nandi; Thomas Santarius; Aswin Chari
Journal:  Neuro Oncol       Date:  2016-05-18       Impact factor: 12.300
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.